ZNTL (Zentalis Pharmaceuticals) Total Liabilities: $70.39 Mil (As of Mar. 2026)


ZNTL Zentalis Pharmaceuticals Inc ZNTL
30 GF Score
Price $4.86
! 3 Warning Signs
View Full Analysis

What is Zentalis Pharmaceuticals Total Liabilities?

Zentalis Pharmaceuticals ZNTL +1.67% 30 Total Liabilities is $70.39 Mil as of Mar. 2026. GuruFocus rates ZNTL with a GF Score™ of 30/100. The stock has 3 warning signs investors should review.

Zentalis Pharmaceuticals's Total Liabilities for the quarter that ended in Mar. 2026 was $70.39 Mil.

Zentalis Pharmaceuticals's quarterly Total Liabilities declined from Sep. 2025 ($74.38 Mil) to Dec. 2025 ($72.76 Mil) and declined from Dec. 2025 ($72.76 Mil) to Mar. 2026 ($70.39 Mil).

Zentalis Pharmaceuticals's annual Total Liabilities declined from Dec. 2023 ($114.30 Mil) to Dec. 2024 ($93.15 Mil) and declined from Dec. 2024 ($93.15 Mil) to Dec. 2025 ($72.76 Mil).

Zentalis Pharmaceuticals Total Liabilities Historical Data

* Premium members only.

The historical data trend for Zentalis Pharmaceuticals's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zentalis Pharmaceuticals Total Liabilities Chart

Zentalis Pharmaceuticals Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial 90.03 105.29 114.30 93.15 72.76

Zentalis Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 88.64 77.21 74.38 72.76 70.39
ZNTL
30GF Score
Zentalis Pharmaceuticals Inc ZNTL
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zentalis Pharmaceuticals Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Zentalis Pharmaceuticals's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=36.559+(35.704+0.50000000000001
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=72.76

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=288.967-216.204
=72.76

Zentalis Pharmaceuticals's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=35.236+(34.65+0.5
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=70.39

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=253.066-182.68
=70.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $70.39 Mil mean?
Zentalis Pharmaceuticals (ZNTL) has a Total Liabilities of $70.39 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Zentalis Pharmaceuticals and its competitors.
Is Zentalis Pharmaceuticals' Total Liabilities too high?
Zentalis Pharmaceuticals' current Total Liabilities is $70.39 Mil. Overall, Zentalis Pharmaceuticals has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Zentalis Pharmaceuticals' Total Liabilities compare to ELDN and GLSI?
Zentalis Pharmaceuticals' Total Liabilities of $70.39 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Zentalis Pharmaceuticals and its competitors. Zentalis Pharmaceuticals's current Total Liabilities is $70.39 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zentalis Pharmaceuticals stock overvalued right now?
Zentalis Pharmaceuticals (ZNTL) has a current Total Liabilities of $70.39 Mil. The current Total Liabilities is $70.39 Mil. Zentalis Pharmaceuticals' overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Zentalis Pharmaceuticals (ZNTL), the current Total Liabilities is $70.39 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zentalis Pharmaceuticals Business Description

Address 10275 Science Center Drive, Suite 200, San Diego, CA, USA, 92121
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
30GF Score

Get the complete analysis for ZNTL

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.86
Price